- Home
- About
- Find staff
- Anna Fager
Anna Fager
-
Evaluation of the flipped dose NIVO3+IPI1 in patients with advanced unresectable
melanoma
Karl Bjorkstrom, Cissi Liu, Anna Fager, Lisa L. Liu, Lars Ny, Hildur Helgadottir
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE - 2025 -
Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain
metastases
Anna Fager, Matilda Samuelsson, Roger Olofsson Bagge, Aldina Pivodic, Sara Bjursten, Max Levin, Henrik Jespersen, Lars Ny
BJC REPORTS - 2025